4 completed, 2 recruiting, 1 unknown. 5 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow Nova Laboratories Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS] Xromi - Sickle Cell Disease | Recruiting | Nova Laboratories Limited | 180 | 2025-06-09 | 2026-03-05 | |
| A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy - Leukemia, Acute Lymphoblastic | Phase 3 | Recruiting | Mats Heyman | 6430 | 2020-07-13 | 2026-08-12 |
| Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®) Azathioprine 50Mg Tab, Azathioprine 10mg/mL oral suspension - Therapeutic Equivalency | Phase 1 | Completed | Nova Laboratories Limited | 30 | 2019-04-11 | 2021-06-22 |
| Pharmacokinetics of Oral Hydroxyurea Solution Oral Hydroxyurea (100 mg/mL) Solution - Sickle Cell Disease, Sickle-Cell; Hemoglobin Disease, Thalassemia | Phase 1 / Phase 2 | Completed | Nova Laboratories Limited | 33 | 2019-01-03 | 2024-10-28 |
| Oral Liquid 13-cis-retinoic Acid (13-CRA) Liquid 13-Cis Retinoic Acid, Extracted capsules 13-CRA - Neuroblastoma | Phase 1 / Phase 2 | Completed | Nova Laboratories Limited | 20 | 2018-04-17 | 2021-10-19 |
| The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) MER4101, Inactivated Influenza Vaccine - Influenza, Human | Phase 1 | Unknown | Nova Immunotherapeutics Limited | 102 | 2015-07-01 | 2019-09-06 |
| Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions Mercaptopurine 20mg/ml oral suspension, Mercaptopurine 50mg tablet - Acute Lymphoblastic Leukemia | Phase 1 | Completed | Nova Laboratories Limited | 70 | 2012-09-01 | 2013-12-02 |
Anemia, Sickle Cell (2) · Hemoglobinopathies (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Hemoglobin SC Disease (1) · Influenza, Human (1) · Leukemia (1) · Neuroblastoma (1) · Thalassemia (1)
Hydroxyurea (2) · Suspensions (2) · Azathioprine (1) · Imatinib Mesylate (1) · Isotretinoin (1) · Mercaptopurine (1) · Solutions (1) · Tablets (1) · blinatumomab (1)
United Kingdom (5) · Germany (2) · Belgium (1) · Denmark (1) · Estonia (1) · Finland (1) · France (1) · Iceland (1) · Ireland (1) · Jamaica (1) · Lithuania (1) · Netherlands (1) · Norway (1) · Portugal (1) · South Africa (1)
Angela E Rankine- Mullings, MD (1) · Geoffrey J Gorse, MD (1) · Hussain Dr Mulla, PhD (1) · Hussain Mulla, PhD (1) · Mats Heyman, MD, PhD (1) · Naimat Khan, MD (1) · Sara Dr Trompeter, MD (1)
PMID 33919763, PMID 35125219, PMID 35125224, PMID 35501736
2017 (1)